Skip to content
healthcare.dev

cilostazol

NDC 50268-177, cilostazol, tablet, from AvPAK.

Product NDC
50268-177
Status
Listed
Labeler
AvPAK
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077030
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50268-177 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CILOSTAZOL100 mg/1

Pharmacologic classes

Phosphodiesterase 3 Inhibitor [EPC]; Phosphodiesterase 3 Inhibitors [MoA]

Package NDCNDC-11Package
50268-177-155026801771550 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-177-15) / 1 TABLET in 1 BLISTER PACK (50268-177-11)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/aec462c8-e225-f520-cae5-80049151c0ff
  • NADAC price for package 50268017715

    GET /v1/drugs/nadac/50268017715

Use it

Look up 50268-177 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50268-177 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50268-177. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.